The most depressing jobs in the country revealed in new study
Job seekers may want to consider the toll that specific careers can have on their mental health.
A huge new study published on Friday examined the relationship between careers and depression rates. The study analyzed survey data from 536,279 workers across 37 states from 2015 to 2019.
Out of half a million U.S. workers, 80,319 of them admitted to being diagnosed with depression at some point during their lives, with women being diagnosed twice as often as men.
Separating the results by industry, the study saw that people who worked in community and social services had the highest rate of lifelong diagnosed depression at 20.5 percent. The second highest on the list was food prep and serving jobs at 20.1 percent.
Other industries with high lifetime diagnosed depression rates are: arts, entertainment, sports, and media at 18.6 percent; accommodation and food services at 18.4 percent; health and social assistance at 18.2 percent; retail trade at 17.7 percent; and legal, education, and library jobs tied at 16.1 percent.
Industries with lower lifetime diagnosed depression rates included mining jobs at 6.7 percent, construction at 8.9 percent, and agriculture and engineering jobs at nine percent.
Although mining and construction may have lower depression rates, those industries also have the highest suicide rates among U.S. workers. The researchers suggest that the gap may be explained because blue-collar men are less likely to seek mental services due to a preexisting stigma or limited access in rural areas.
Despite the results of the study, there are some jobs out there that are almost stress-free and also come with a large paycheck. Back in December 2024, Resume Genius released its list of the highest-paying jobs that also reported low levels of stress.
Their study described 'low-stress jobs' as ones that typically require fewer demands, more predictable work hours, supportive environments, and manageable workloads.
All of the jobs on the list required the person to have at least a Bachelor's degree. The list was compiled using data from the U.S. Bureau of Labor Statistics (BLS) and the career site O*NET Online. The high-stress jobs were filtered out using O*NET and then cross-referenced against the BLS's Occupational Outlook Handbook, with the national median salary set at $48,060 and viewing jobs that showed 'faster-than-average growth.'
The best jobs included: water source specialist, astronomer, actuary, environmental economist, mathematician, and geographer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
The most depressing jobs in the country revealed in new study
Job seekers may want to consider the toll that specific careers can have on their mental health. A huge new study published on Friday examined the relationship between careers and depression rates. The study analyzed survey data from 536,279 workers across 37 states from 2015 to 2019. Out of half a million U.S. workers, 80,319 of them admitted to being diagnosed with depression at some point during their lives, with women being diagnosed twice as often as men. Separating the results by industry, the study saw that people who worked in community and social services had the highest rate of lifelong diagnosed depression at 20.5 percent. The second highest on the list was food prep and serving jobs at 20.1 percent. Other industries with high lifetime diagnosed depression rates are: arts, entertainment, sports, and media at 18.6 percent; accommodation and food services at 18.4 percent; health and social assistance at 18.2 percent; retail trade at 17.7 percent; and legal, education, and library jobs tied at 16.1 percent. Industries with lower lifetime diagnosed depression rates included mining jobs at 6.7 percent, construction at 8.9 percent, and agriculture and engineering jobs at nine percent. Although mining and construction may have lower depression rates, those industries also have the highest suicide rates among U.S. workers. The researchers suggest that the gap may be explained because blue-collar men are less likely to seek mental services due to a preexisting stigma or limited access in rural areas. Despite the results of the study, there are some jobs out there that are almost stress-free and also come with a large paycheck. Back in December 2024, Resume Genius released its list of the highest-paying jobs that also reported low levels of stress. Their study described 'low-stress jobs' as ones that typically require fewer demands, more predictable work hours, supportive environments, and manageable workloads. All of the jobs on the list required the person to have at least a Bachelor's degree. The list was compiled using data from the U.S. Bureau of Labor Statistics (BLS) and the career site O*NET Online. The high-stress jobs were filtered out using O*NET and then cross-referenced against the BLS's Occupational Outlook Handbook, with the national median salary set at $48,060 and viewing jobs that showed 'faster-than-average growth.' The best jobs included: water source specialist, astronomer, actuary, environmental economist, mathematician, and geographer.
Yahoo
a day ago
- Yahoo
KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")
Recent clinical and pre-clinical studies and analysis indicates the potential to increase lifespan and reduce age-associated degeneration in multiple organ systems has be realized with a focus on the human gene called Klotho. NEW YORK, June 9, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company announced the findings of pre-clinical studies indicating the potential of elevating Klotho gene expression to simultaneously reduce the age-associated degeneration in multiple organs, increasing both life and health span. Pioneering discoveries by Professor Makoto Kuro-O in 1997 showed that Klotho concentrations in the blood were directly associated with lifespan of mammals – the lower the Klotho blood levels the shorter the lifespan. Kuro-O's laboratory then published the first evidence that genetic over expression of the full-length form of Klotho in mice, increased in lifespan of mice of up to 30%-40% longer compared to the normal mouse lifespan. Since then, the Klotho protein has gained much attention because of its ability to influence key biological pathways involved in metabolism, inflammation and tissue repair, which are closely linked to the aging process. A series of experiments led by Joan Roig-Soriano and colleagues, published in the February 2025 edition of Molecular Therapy, highlights the promising role of the naturally occurring secreted form of the Klotho protein ("s-KL") and its effects on healthy aging mice and mice with a rapidly aging phenotype. Key observations were that, while aging is a major risk factor for many pathologies, including cognitive decline, neuroinflammation, sarcopenia, and osteoporosis, the secreted protein s-KL has emerged as a potentially promising therapeutic anti-aging molecule due to its many biological effects involving multiple pathways related to cell injury, stress, and inflammation. The s-KL was administered using an adeno-associated virus serotype 9 delivery vector (AAV9) that expressed the secreted KL protein isoform and efficiently increased the concentration of s-KL in serum, resulting in a 20% increase in lifespan. Dr. Joseph Sinkule, the CEO of Klotho Neurosciences (KLTO) commented that "KLTO has secured an exclusive worldwide license for s-Kl from Universitat Autònoma de Barcelona (UAB) and Institució Catalana de Recerca i Estudis Avançats (ICREA) in Spain. As a result, we have the exclusive use of patents issued in the USA, Europe, and China covering a secreted splice variant of mammalian Klotho referred to as s-KL, as a treatment for neurodegenerative and age -related disorders. Professor Makoto Kuro-O is also a scientific advisor to KLTO. This recently published paper provides further credence to our development of s-KL as a treatment to reduce age-associated degeneration where, as a company, KLTO has a particular focus on neurodegenerative diseases such as ALS, Alzheimer's and Parkinson's disease. The results disclosed in the paper show the potential of elevating s-KL protein expression, resulting in the reduction of age-associated degeneration in multiple organs, increasing both life and health span". About Klotho Neurosciences, Inc. Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the "anti-aging" human Klotho gene (s-KL), and it's novel delivery systems to transform and improve the treatment of neurodegenerative and age-related disorders such as ALS, Alzheimer's, and Parkinson's disease. The company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. The company is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical product development and commercialization. For more information, contact:Investor Contact and Corporate Communications - Jeffrey LeBlanc, CFOjeff@ Website: Forward-Looking Statements: This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company's future commercial operations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company's inability to implement its business plans, identify and realize additional opportunities, or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the documents filed or to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC") from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC's website, All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law. View original content to download multimedia: SOURCE Klotho Neurosciences, Inc.
Yahoo
7 days ago
- Yahoo
Tariff uncertainty is hammering one of America's favorite food escapes — snacks
Tariff uncertainty and inflation are driving consumer decisions at the grocery stores, and for big packaged food companies, one key area is bearing the brunt of these changes: snacking. In its quarterly report released Monday, Campbell's (CPB), which owns snack brands like Goldfish crackers and Cape Cod chips, said that it saw "increased headwinds" in snacking, leading to a 5% decline in volume mix and an 8% decrease in revenue in its fiscal third quarter results. Consumers "are increasingly intentional about the discretionary snack purchases," CEO Mick Beekhuizen told investors on the company's earnings call, a trend that has only gotten worse as the year's gone on. "If you look at the quarter, Q3, and you put it in perspective versus Q2, you see... the aggregate categories deteriorated... driven by the deteriorating consumer confidence," Beekhuizen added. Campbell's is only the latest in a series of packaged food giants to call out a shift in snacking behavior. "Revenue management clearly is becoming more complex," PepsiCo (PEP) CEO Ramon Laguarta told investors on the company's earnings call in late April, "as consumers are feeling more challenged with their disposable income." Laguarta said consumers' approach to shopping changed in the quarter. In early April, consumers were looking to see how much they got per item, and by the end of the month, they were more focused on the "absolute price per unit." Pepsi's snack portfolio includes Frito-Lay brands like Lays, Cheetos, Doritos, and Tostitos, among others. Kraft Heinz's (KHC) portfolio overall — ranging from Jell-O to Lunchables — saw its volume mix drop 5.6 percentage points in the quarter. Kellanova (K), which is behind brands like Cheez-Its and Pringles, saw its volume decline in North America. The company is in the process of being acquired by Mars. The summer months could potentially catalyze a turnaround in consumer habits, with holidays offering what Kraft Heinz CEO Carlos Abrams-River called "volume opportunities" on the company's latest earnings call in late April. Winning holidays is crucial. "Holidays matter... It's like holidays are almost worth double relative to a regular week," Bank of America analyst Peter Galbo told Yahoo Finance. Better weather also plays a key role. For example, if Memorial Day weather isn't very good in much of the country, it can create a "meaningful swing factor" for snacks. If "the weather is bad," Galbo added, "You're not going to have a barbecue, so you don't buy Tostitos or Lays." This snacking slowdown also comes as consumer confidence has fallen sharply, rising in May for the first time all year. At the same time, the US labor market is beginning to show some cracks, with the number of Americans collecting unemployment checks in mid-May standing at the highest in 3.5 years. Uncertainty surrounding tariffs has also weighed on pricing and the consumer outlook. Data from PwC found prices for shelf-stable categories like sauces, pasta, canned beans, and snacks are up 1%-6% over the last week due to the impact of tariffs. Read more: What Trump's tariffs mean for the economy and your wallet From a product packaging and ingredient standpoint, Galbo said he doesn't expect tariffs to impact snacks, which are mostly sourced domestically or from Canada, which is likely exempt as a result of the USMCA. Inflation data out last month showed grocery prices fell 0.4% in April while overall food inflation fell 0.1%, the sharpest drop in both measures since 2020. Still, measures like this year's spike — and then sharp decline — in egg prices show consumers navigating a volatile food pricing environment and acting with caution as they roam the aisles. "Snacking is way more discretionary than we probably all thought it was, as opposed to being a staple," Galbo said. "Which is what these companies were supposed to be." Brooke DiPalma is a senior reporter for Yahoo Finance. Follow her on X at @BrookeDiPalma or email her at bdipalma@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
